These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 18089597

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
    Col NF, Guthrie JR, Politi M, Dennerstein L.
    Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E.
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [Abstract] [Full Text] [Related]

  • 45. The length of perimenopausal menstrual cycles increases later and to a greater degree than previously reported.
    Ferrell RJ, Simon JA, Pincus SM, Rodríguez G, O'Connor KA, Holman DJ, Weinstein M.
    Fertil Steril; 2006 Sep; 86(3):619-24. PubMed ID: 16889776
    [Abstract] [Full Text] [Related]

  • 46. The roles of biologic and nonbiologic factors in cultural differences in vasomotor symptoms measured by surveys.
    Crawford SL.
    Menopause; 2007 Sep; 14(4):725-33. PubMed ID: 17279061
    [Abstract] [Full Text] [Related]

  • 47. Negative affect and vasomotor symptoms in the Study of Women's Health Across the Nation Daily Hormone Study.
    Gibson CJ, Thurston RC, Bromberger JT, Kamarck T, Matthews KA.
    Menopause; 2011 Dec; 18(12):1270-7. PubMed ID: 21900850
    [Abstract] [Full Text] [Related]

  • 48. Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of wake-time variability.
    Bedford JL, Prior JC, Hitchcock CL, Barr SI.
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):76-80. PubMed ID: 19552997
    [Abstract] [Full Text] [Related]

  • 49. Improved performance of ELISAs for fertility assessment using common reagents and assay protocol as evidence from quality control studies.
    Desai MP, Donde UM, Khatkhatay MI.
    J Immunoassay Immunochem; 2002 Sep; 23(2):163-80. PubMed ID: 12033641
    [Abstract] [Full Text] [Related]

  • 50. Symptoms in the menopausal transition: hormone and behavioral correlates.
    Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S.
    Obstet Gynecol; 2008 Jan; 111(1):127-36. PubMed ID: 18165401
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Studies on the urinary excretion of gonadotrophins during the normal menstrual cycle in young women.
    Papanicolaou AD, Adamopoulos DA, Loraine JA, Lunn SF.
    J Obstet Gynaecol Br Commonw; 1970 Nov; 77(11):961-6. PubMed ID: 5483418
    [No Abstract] [Full Text] [Related]

  • 55. Ovarian steroids and premenstrual symptoms: a comparison of group differences and intra-individual patterns.
    Lentz MJ, Woods N, Heitkemper M, Mitchell E, Henker R, Shaver J.
    Res Nurs Health; 2007 Jun; 30(3):238-49. PubMed ID: 17514719
    [Abstract] [Full Text] [Related]

  • 56. Urinary steroids, FSH and CG measurements for monitoring the ovarian cycle and pregnancy in the chimpanzee.
    Shimizu K, Douke C, Fujita S, Matsuzawa T, Tomonaga M, Tanaka M, Matsubayashi K, Hayashi M.
    J Med Primatol; 2003 Feb; 32(1):15-22. PubMed ID: 12733598
    [Abstract] [Full Text] [Related]

  • 57. Comparison between creatinine and pregnanediol adjustments in the retrospective analysis of urinary hormone profiles during the human menstrual cycle.
    Miro F, Coley J, Gani MM, Perry PW, Talbot D, Aspinall LJ.
    Clin Chem Lab Med; 2004 Feb; 42(9):1043-50. PubMed ID: 15497471
    [Abstract] [Full Text] [Related]

  • 58. The relation between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women's Health in the Lund Area (WHILA) study.
    Teleman PM, Persson J, Mattiasson A, Samsioe G.
    Acta Obstet Gynecol Scand; 2009 Feb; 88(8):927-32. PubMed ID: 19579140
    [Abstract] [Full Text] [Related]

  • 59. Symptoms reported by women in midlife: menopausal transition or aging?
    Berecki-Gisolf J, Begum N, Dobson AJ.
    Menopause; 2009 Feb; 16(5):1021-9. PubMed ID: 19546824
    [Abstract] [Full Text] [Related]

  • 60. Actigraphic and self-reported sleep quality in women: associations with ovarian hormones and mood.
    Li DX, Romans S, De Souza MJ, Murray B, Einstein G.
    Sleep Med; 2015 Oct; 16(10):1217-24. PubMed ID: 26429749
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.